Stockreport

CEO & Director of ALX Oncology Holdings Picks Up 69% More Stock [Yahoo! Finance]

ALX Oncology Holdings Inc.  (ALXO) 
PDF NASDAQ:ALXO ) CEO & Director, Jason Lettmann, recently bought US$99k worth of stock, for US$1.08 per share. Even though that isn't a massive buy, it did increase their h [Read more]